INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED FILES APPLICATION FOR "ANTI-IL-5 ANTIBODY IN THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS"

GENEVA, April 18 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GSK Medicines Research Centre Gunnels Wood RoadStevenage Hertfordshire SG1 2NY) filed a patent application (PCT/EP2025/079082) for "ANTI-IL-5 ANTIBODY IN THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS" on Oct 09, 2025. With publication no. WO/2026/078117, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE SOUSA DOHERTY, Ana Rosario Camoes Afonso Ventura (GSK79 New Oxford StreetLondon WC1A 1DG), DAVIS, Angela Marie (GSK406 Blackwell S...